Death Clock, an AI-powered longevity app launched in 2024, estimates users' life expectancy based on lifestyle data and now offers optional biomarker blood panels for an additional fee. A basic panel costs $69 and checks markers like cholesterol, blood sugar, inflammation and vitamin D, while a fuller set of nine additional tests covering hormones, micronutrients and thyroid function costs $780. The writer tried the app and received a predicted death date in 2060 at age 74.
wired.com
· 2026-10-29
A growing movement in psychiatry aims to replace broad, symptom-based diagnoses with data-driven subgroups that combine genetics, brain scans, speech and sleep patterns, and environmental factors like pollution or socio-economic status. Researchers are developing algorithms that compare a patient's data with thousands of others to recommend treatments more likely to work for them. Those shaping the DSM, psychiatry's main diagnostic manual, are reportedly exploring how to incorporate such environmental and social variables into future editions.
nature.com
· 2026-10-28
TimeTeller, a German startup led by CEO Angela Relógio, is now selling a direct-to-consumer saliva test kit that measures a person's circadian rhythm. Relógio, a physicist and former oncology researcher, says the company began taking direct orders due to demand from longevity clinics seeking data to personalize sleep, nutrition and activity advice. She stresses the consumer kit does not yet determine optimal timing for cancer treatments, which requires separate clinical research.
techcrunch.com
· 2026-10-14
A writer recounts their son's diagnosis at 18 with a disease typically seen in patients in their late sixties, describing how the experience reshaped their view of AI's role in medicine. The essay argues that despite growing public backlash against AI, the technology holds promise for personalizing healthcare, especially for patients whose conditions don't fit standard patterns.
fastcompany.com
· 2026-09-30